DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20183658

Assessment of role of genetic polymorphisms in XRCC1, XRCC2 and XRCC3 genes in cervical cancer susceptibility from a rural population: a hospital based case-control study from Maharashtra, India

Kailas D. Datkhile, Madhavi N. Patil, Pratik P. Durgawale, Shreepad A. Joshi, Kalpita S. Korabu, Satish V. Kakade

Abstract


Background: Cervical cancer is a major concern of health risk, moreover the leading cause of cancer causing deaths in women of rural parts of India. This study was aimed to assess the risk of cervical cancer development in association with polymorphisms in X-Ray Cross Complementing Group (XRCC1, XRCC2 and XRCC3) genes in the rural population of south-western Maharashtra. We focused to determine the frequency of polymorphisms in DNA repair genes including XRCC1 at codon (cd) 194, cd 280, cd 399, XRCC2 at cd 188 and XRCC3 at cd 241 and their plausible role in cervical cancer risk from rural parts of India.

Methods: This study included 350 proven cases with cervical cancer and 400 age and sex matched controls. We used polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to analyze the association XRCC1, XRCC2 and XRCC3 gene polymorphisms with cervical cancer development in women of South-Western Maharashtra.

Results: The result from our study showed that allele frequencies of selected genes were not statistically different between the groups for XRCC1 Trp194, XRCC2 His188 and XRCC3 Met241. XRCC1 His280 (OR= 4.36; 95% CI= (3.20-5.95); p= <0.0001) and XRCC1 Gln399 (OR= 2.99; 95% CI= (1.60-5.56); p= <0.0001) genotypes significantly increased the risk of cervical cancer.

Conclusions: This study indicates that polymorphisms in cd 280 of exon 9 and cd 399 of exon 10 of XRCC1 gene could play a role in modifying genetic susceptibility of individuals towards cervical cancer among women from rural Maharashtra. This case-control study suggest that selected DNA repair genes represent genetic determinants in cervical carcinogenesis along with other risk factors in the rural Indian population.


Keywords


Cervical cancer, Genetic polymorphisms, PCR-RFLP, XRCC1, XRCC2, XRCC3

Full Text:

PDF

References


World Health Organization. IARC monographs on the evaluation of carcinogenic risk to humans. Volume 90. Human papillomaviruses. Lyon (France): International Agency for Research on Cancer. 2007.

Jemal A, Bray F, Center MM, Ferlay F, Ward E, Forman D. Global cancer statistics. Ca Cancer J Clin. 2011;61:69-90.

World Health Organization. Information Centre on HPV and Cervical Cancer (HPV Information Centre): Summary Report on HPV and Cervical Cancer Statistics in South Africa.(Onlin). 2010.

Sharma N, Sharma V, Singh PR, Kushwaha RS, Nautiyal SC, Sailwal S, et al. Age wise distribution of high risk Human Papillomavirus in Northern Indian women. Biomed Res India. 2012;23:547-50.

Nunobiki O, Ueda M, Toji E, Yamamoto M, Akashi K, Sato N, et al. Genetic polymorphism of cancer susceptibility genes and HPV infection in cervical carcinogenesis. Pathology Research International. 2011.

Thacker J, Zdzienicka MZ. The mammalian XRCC genes: their roles in DNA repair and genetic stability. DNA Repair (Amst). 2003;2:655-72.

Vidal AE, Boiteux S, Hickson ID, Radicella JP. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J. 2001;20:6530-9.

Mathonnet G, Labuda D, Meloche C, Wambach T, Krajinovic M, Sinnett D. Variable continental distribution of polymorphisms in the coding regions of DNA-repair genes. J Human Genetics. 2003;48(12):659.

Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiology and Prevention Biomarkers. 2003 Aug 1;12(8):689-98.

Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1513-30.

Au WW, Navasumrit P, Ruchirawat M. Use of biomarkers to characterize functions of polymorphic DNA repair genotypes. Int J Hyg Environ Health. 2004;207:301-13.

Wei B, Zhou Y, Xu Z, Ruan J, Zhu M, Jin K, et al. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis. Prostate cancer and prostatic diseases. 2011;14(3):225-31.

Dai L, Duan F, Wang P, Song C, Wang K. XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep. 2012;39:9535-47.

Datkhile KD, Vhaval RD, Patil MN, Khamkar TS, Durgavale PP, Gudur A. Role of genetic polymorphisms in DNA repair genes ((XRCC1, XRCC2, XRCC3, XRCC4, XRCC5, XRCC6, XRCC7) in head and neck cancer susceptibility in rural Indian population: A hospital based casecontrol study from south-western Maharashtra. Int J Curr Res. 2016;8:25482-92.

Bin K, Zhi-Dong L, Li C, Ruo-Wu S, Li-Ying J, Zhao-Chuan Y. Lack of an association between XRCC2 R188H polymorphisms and breast cancer: an update meta-analysis involving 35,422 subjects. Int J Clin Exp Med. 2015;8:15808-14.

Huang G, Cai S, Wang,W, Zhang Q and Liu A. Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: A meta-analysis from case-control studies. PLoSOne. 2013;8(8):e68457.

Qureshi Z, Mahjabeen I, Baig R, Kayani M. Correlation between selected XRCC2, XRCC3 and RAD51 gene polymorphisms and primary breast cancer in women in Pakistan. Asian Pac J Cancer Prev. 2014;15:10225-9.

Wang X, Yang Z. The relationship of XRCC1 gene polymorphism and the risk of cervical cancer. Modern Medicine and Health. 2010;26:2137-8.

Settheetham-Ishida W, Yuenyao P, Natphopsuk S, Settheetham D, Ishida T. Genetic Risk of DNA Repair Gene Polymorphisms (XRCC1 and XRCC3) for High Risk Human Papillomavirus Negative Cervical Cancer in Northeast Thailand. Asian Pac J Cancer Prev. 2011;12:963-6.

Perez LO, Crivaro A, Barbisan G Poleri L, Golijaw CD. XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk. Pathol. Oncol. Res. 2013;19(3):553-558.

Zhang L, Ruan Z, Hong Q, Gong X, Hu Z, Huang Y, Xu A. Single nucleotide polymorphisms in DNA repair genes and risk of cervical cancer: a case-control study. Oncol Lett. 2012;3:351-62.

Bajpai D, Banerjee A, Pathak S, Jain S, Singh N. Prognostic importance of DNA repair gene polymorphisms in cervical cancer patients from India. Sex Transm Infect. 2015;91:A167.

Konathala G, Mandarapu R and Godi S. Data on polymorphism of XRCC1 and cervical cancer risk from South India. Data in Brief. 2017;10:11-3.

Park JY, Lee SY, Jeon HS, Bae NC, Chae SC, Joo S, et al. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiology and Prevention Biomarkers. 2002;11(1):23-7.

Kim SU, Park SK, Yoo KY, Yoon KS, Choi JY, Seo JS, et al. XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics and Genomics. 2002;12(4):335-8.

Liu DY, Liang HC, Xiao XM. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis. Genet Mol Res. 2015;14:9821-8.

Pachouri SS, Sobti RC, Kaur P and Singh J. Contrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in North Indian population. DNA Cell Biol. 2007;26:186-91.

Vettriselvi V, Vijayalakshmi K, Solomon FD, Paul VP. XRCC1 and XPD Gene Polymorphisms in a South Indian Population. Asian Pacific J Cancer Prev. 2007;8:283-6.

Mei J, Duan HX, Wang LL, Yang S, Lu JQ, Shi TY, Zhao Y. XRCC1 polymorphisms and cervical cancer risk: an updated meta-analysis. Tumour Biol. 2014;35:1221-31.

Shuai HL, Luo X, Yan RL, Li J, Chen DL. XRCC1 polymorphisms are associated with cervical cancer risk and response to chemotherapy: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2012;13:6423-7.

Cai Y, Wang QM, Feng JH, Chen L, Zhang ST, Huang Y. Association between XRCC1 Arg399Gln, Arg280His, Arg194Trp polymorphisms and cervical cancer risk: a pooled analysis based on Chinese individuals. Int J Clin Exp Med. 2017;10(9):13003-8.

Zeng X, Zhang Y, Yue T, Zhang T, Wang J, Xue Y, An R. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects. Oncotarget. 2017;8(2):2249-60.